Impact of the COVID-19 national lockdown in the allergic rhinitis symptoms in patients treated with immunotherapy at two allergy referral centers in Bogotá, Colombia.

Lucía C Pérez-HerreraSebastián Ordoñez-CerónSergio Moreno-LópezDaniel PeñarandaElizabeth GarcíaAugusto Peñaranda

Published in: Laryngoscope investigative otolaryngology (2022)

A large proportion of patients reported worsening of their AR symptoms, probably due to higher exposure to indoor AR allergens and interruption of immunotherapy during COVID-19 lockdowns.

Keyphrases

allergic rhinitis
end stage renal disease
coronavirus disease
ejection fraction
sars cov
newly diagnosed
primary care
prognostic factors
air pollution
heavy metals
patient reported